SCHEMBL9053528

SCHEMBL9053528

Cc1ccc(S(=O)(=O)Oc2cc(C(=O)O)cc(N)c2O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.50
GAA P10253 5/20 0.46
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
ESR1 P03372 1/20 0.46
ESR2 Q92731 1/20 0.46
MAPT P10636 4/20 0.45
ALDH1A1 P00352 3/20 0.44
STAT3 P40763 1/20 0.42
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41
G6PD P11413 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
GFER P55789 2/20 0.41
NPC1 O15118 2/20 0.41
KDM4E B2RXH2 1/20 0.41
PKM P14618 2/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7937565 0.89 PTGS2 (0.51) CYP1A2GAAKMT2AMEN1ESR1
SCHEMBL9053535 0.85 CYP1A2 (0.51) CYP1A2GAAKMT2AMEN1ESR1
SCHEMBL9053867 0.83 ALDH1A1 (0.48) CYP1A2GAAKMT2AMEN1MAPT
SCHEMBL9056190 0.81 GAA (0.41) CYP1A2GAAKMT2AMEN1ESR1
SCHEMBL9052978 0.81 PTGS2 (0.47) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL9054847 0.81 HTT (0.54) CYP1A2GAAKMT2AMEN1ESR1
SCHEMBL9053651 0.80 KMT2A (0.50) CYP1A2GAAKMT2AMEN1ESR1
SCHEMBL7931629 0.78 ALDH1A1 (0.53) GAAKMT2AMEN1MAPTALDH1A1
SCHEMBL9054697 0.77 KMT2A (0.47) GAAKMT2AMEN1ESR1ESR2
SCHEMBL7632373 0.76 GAA (0.53) GAAKMT2AMEN1ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996008483-A1 GALLIC ACID DERIVATIVES, METHOD FOR THEIR PREPARATION AND THEIR USE AS DRUGS ROUSSEL UCLAF (FR) 1996-03-21 WO disclosed